CARISMA Therapeutics Inc (CARM)
1.23
+0.08
(+6.96%)
USD |
NASDAQ |
Jun 26, 15:30
CARISMA Therapeutics Shareholders Equity (Quarterly): 10.90M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 10.90M |
| December 31, 2023 | 26.53M |
| September 30, 2023 | 46.30M |
| June 30, 2023 | 66.70M |
| Date | Value |
|---|---|
| March 31, 2023 | 86.07M |
| December 31, 2022 | -157.06M |
| June 30, 2022 | -14.58M |
| December 31, 2021 | 11.63M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-157.06M
Minimum
Dec 2022
86.07M
Maximum
Mar 2023
9.560M
Average
19.08M
Median
Shareholders Equity (Quarterly) Benchmarks
| Verastem Inc | 46.22M |
| Aquestive Therapeutics Inc | -36.30M |
| Gritstone Bio Inc | 13.96M |
| Black Diamond Therapeutics Inc | 104.31M |
| Moderna Inc | 12.82B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 73.80M |
| Total Liabilities (Quarterly) | 62.90M |
| Current Ratio | 4.638 |
| Net Debt Paydown Yield | 7.15% |